PUTEAUX, France, March 21, 2024--(BUSINESS WIRE)--Regulatory News: ORPEA S.A (the "Company") (Paris:ORP) announces the completion today of the reverse share split of all outstanding shares of the Company (the "Reverse Share Split"). In the context of the Reverse Share Split: One thousand (1,000) existing shares with a par value of one euro cent (0.01) were exchanged for one (1) new share with a par value of ten (10.00) euros; As a result, 159,191,703,111 existing shares with a par value of one euro cent (0.01) each were exchanged for 159,191,703 new shares with a par value of ten (10.00) euros each; The new shares of the Company will be admitted to trading on Euronext Paris as from March 22, 2024, the first day of trading, under the new ISIN code FR001400NLM4; The new shares of the Company will be eligible for the deferred settlement service (DSS) as from March 22, 2024; The new shares will be evidenced by book-entry (inscription en compte) on March 26, 2024 (payment date); The Company's share capital amounts to EUR 1,591,917,030, divided into 159,191,703 ordinary shares with a par value of ten (10.00) euros each. Shareholders who were unable to hold a multiple of one thousand (1,000) existing shares will be compensated for their fractional rights within a maximum of thirty (30) days by their financial intermediary, i.e. up to and including April 23, 2024. Shareholders are advised to contact their financial intermediary should they have any questions on this subject. About emeis With 76,000 experts and professionals in healthcare, care, and supporting the most vulnerable among us, emeis operates in 20 countries with five core activities: psychiatric clinics, medical care and rehabilitation clinics, nursing homes, home care services, and assisted-living facilities. Every year, emeis welcomes 267,000 residents, patients, and other beneficiaries. emeis is committed and taking action to rise to a major challenge facing our civilisation, i.e. the increase in the number of people put in a vulnerable position as a result of accidents, old age, or the rising number of cases of mental illness. ORPEA S.A., the Group's parent company is 50.2 % owned by Caisse des Dépôts, CNP Assurances, MAIF, and MACSF Epargne Retraite. It is listed on the Euronext Paris stock exchange (ISIN: FR0000184798) and a member of the SBF 120 and CAC Mid 60 indices. Website: www.emeis.com View source version on businesswire.com: https://www.businesswire.com/news/home/20240321459433/en/ Contacts Press Contacts Isabelle Herrier Naufle Medias & e-reputation Director 07 70 29 53 74 [email protected] IMAGE 7 Charlotte LE BARBIER // Laurence HEILBRONN 06 78 37 27 60 // 06 89 87 61 37 [email protected] // [email protected] Investor Relations Benoit LESIEUR Investor Relations Director [email protected] Toll-free number for shareholders: 0 805 480 480 NEWCAP Dusan ORESANSKY 01 44 71 94 94 [email protected]
ORPEA S.A. Announces the Completion of the Reverse Share Split of Its Outstanding Shares
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...